AbbVie tops quarterly expectations as newer immunology drugs offset Humira decline

Investing.com Gold reports: AbbVie tops quarterly expectations as newer immunology drugs offset Humira decline. Full body text was unavailable at ingest time, so this brief is based on headline context.